Advertisement
Canada markets closed
  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • Bitcoin CAD

    83,245.55
    -2,797.98 (-3.25%)
     
  • CMC Crypto 200

    1,259.23
    -98.78 (-7.28%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     
  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     

NewsBreak: Probe Finds Chemical in Vaping Linked to Lung Illness - Report

Investing.com - U.S. state and federal health officials linked the same chemical found in marijuana products to vaping products, which have led to lung illnesses, the Washington Post reported Thursday.

The chemical, an oil derived from vitamin E, could be associated with recently reported respiratory symptoms, including cough, shortness of breath and chest pain, the Post said, citing officials who took part in a call between the FDA and state health officials.

There have been 215 possible cases of lunge illnesses linked to vaping reported from 25 states as of Aug 27.

- Philip Morris International (NYSE:PM) was down 0.8% at 3:15 PM ET (19:15 GMT) and Altria (NYSE:MO) fell 0.4%.

ADVERTISEMENT

Related Articles

Huntington among companies awarded U.S. government contract potentially valued at $17 billion

Ray Dalio Sees 25% Chance of Recession This Year and in 2020

Buy-the-Dip Bond Traders Are Scared of Momentum